Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02310763
Brief Title: A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

First Submitted : November 4, 2014
First Submitted that Met QC Criteria : December 4, 2014
First Posted : December 8, 2014 (Estimate)

Results First Submitted : April 29, 2019
Results First Submitted that Met QC Criteria : July 3, 2019
Results First Posted : July 23, 2019

Last Update Submitted that Met QC Criteria : July 3, 2019
Last Update Posted : July 23, 2019